Skip to Main Content

Paper Details

CD56<sup>bright</sup> natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-<i>versus</i>-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.
Haematologica
18
2017
-stimulated apheresis peripheral blood, CD56bright, CD56bright natural, CD56bright natural killer regulatory cells, activated B cells, central memory and effector T cells, chronic, chronic graft-versus-host disease, clinicaltrials, dendritic cell populations, filgrastim, filgrastim primed, filgrastim-stimulated apheresis peripheral blood, filgrastim-stimulated bone marrow, graft-versus-host disease, human, human leukocyte antigen, interferon, interferon positive producing T cells, interferon -producing T helper cells, macrophages, memory B cells, natural killer T cells, natural killer cells, patient, regulatory T cells, stem cell source
Author NameAffiliation
Clayton A SmithUniversity of Colorado Hospital
Sara MostafaviUniversity of British Columbia
Sara MostafaviUniversity of British Columbia
Steven Z PavleticCenter for Cancer Research, National Cancer Institute
Steven Z PavleticCenter for Cancer Research, National Cancer Institute
  • 1 - 5

Datasets

Release 1.2